Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Utrogestan for treatment of idiopathic intrauterine growth restriction
IRCT2017081510222N11Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of progesterone in intrauterine growth restriction (IUGR), sponsored by Shahrekord University of Medical Sciences. Started Sep 2017; status: completed.
02
Drugs
progesterone
03
Conditions
intrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on IRCT2017081510222N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017081510222N11.